News | August 27, 2008

Radiation Oncology Site Visits Rose 5 Percent in 2007

August 28, 2008 – Patients made an estimated 24.5 million radiation therapy or related visits to 2,110 U.S. radiation oncology sites in 2007, approximately a 5 percent increase over 23.2 million visits in 2006, reported IMV Medical Information Division in a recent study.

The top three cancer site types include prostate, breast and lung cancer, which account for 21 percent, 20 percent and 13 percent, respectively, of all cancer site types treated using radiation therapy.

“While the number of patients treated with radiation therapy every year is relatively stable, the technological sophistication of radiation oncology departments is continuing to advance. Digital imaging has become integrated into treatment planning and to guide tumor treatment real-time,” observed Lorna Young, senior director, Market Research. “Over half of the radiation oncology sites provide treatments using image-guided radiotherapy (IGRT), up from 15 percent of the sites in 2004, using either a dedicated IGRT imaging device or electronic portal imaging. Ultrasound, X-ray and CT are the primary imaging modalities used in IGRT.”

The report also found that nearly all (97 percent) of the radiation therapy treatment plans use CT images, 11 percent use MRI and 11 percent use PET images; and CT simulators comprised over 90 percent of the simulators installed in 2007.

The study also reported that intensity-modulated radiotherapy (IMRT) has been adopted by 87 percent of the radiation oncology sites. Plus, sites having budgets of $1.5 million have increased from 15 percent of 2003 capital budgets to 32 percent of 2008 budgets.

The data source for this report is IMV’s 2006/07 Radiation Oncology Census Database, which provides profiles of radiation oncology sites in the U.S.

Source: IMV Medical Information Division

For more information: www.imvinfo.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more